Rock Springs Capital Management LP Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$2.4T
Holdings
131
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (131 positions)
| Stock | Value |
|---|---|
NBIXNEUROCRINE BIOSCIENCES INC | $116.8M |
ISRGINTUITIVE SURGICAL INC | $75.5M |
UNHUNITEDHEALTH GROUP INC | $74.8M |
BIIBBIOGEN INC | $56.9M |
IRTCIRHYTHM TECHNOLOGIES INC | $52.5M |
BAXBAXTER INTL INC | $52.4M |
EHCENCOMPASS HEALTH CORP | $52.2M |
HUMHUMANA INC | $49.5M |
PODDINSULET CORP | $48.4M |
HCAHCA HEALTHCARE INC | $46.7M |
CNCCENTENE CORP DEL | $44.6M |
ACADACADIA PHARMACEUTICALS INC | $43.3M |
2L9BLUEPRINT MEDICINES CORP | $43.1M |
—FORTY SEVEN INC | $42.7M |
ALNYALNYLAM PHARMACEUTICALS INC | $41.5M |
ZLABZAI LAB LTD | $38.6M |
TFXTELEFLEX INCORPORATED | $38.1M |
AGIOAGIOS PHARMACEUTICALS INC | $37.4M |
EWEDWARDS LIFESCIENCES CORP | $36.6M |
PENPENUMBRA INC | $36.3M |
BSXBOSTON SCIENTIFIC CORP | $35.9M |
NVROEURNEVRO CORP | $34.6M |
GLPGGALAPAGOS NV | $34.3M |
SRPTSAREPTA THERAPEUTICS INC | $33.8M |
RAREULTRAGENYX PHARMACEUTICAL IN | $33.2M |
ARGXARGENX SE | $32.6M |
BMRNBIOMARIN PHARMACEUTICAL INC | $32.1M |
CHRSCOHERUS BIOSCIENCES INC | $31.6M |
—EPIZYME INC | $30.3M |
IDXXIDEXX LABS INC | $30.3M |
PCRXPACIRA BIOSCIENCES | $30.2M |
VRTXVERTEX PHARMACEUTICALS INC | $29.7M |
SGENEURSEATTLE GENETICS INC | $27.9M |
APLTAPPLIED THERAPEUTICS INC | $27.6M |
ARDXARDELYX INC | $27.6M |
ONCBEIGENE LTD | $26.4M |
MRTXEURMIRATI THERAPEUTICS INC | $26.3M |
AMGNAMGEN INC | $25.5M |
FRPTFRESHPET INC | $25.4M |
CICIGNA CORP NEW | $25.0M |
EXASEXACT SCIENCES CORP | $24.6M |
ASNDASCENDIS PHARMA A S | $24.0M |
ASMBASSEMBLY BIOSCIENCES INC | $22.2M |
AFWALIGN TECHNOLOGY INC | $22.2M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $19.2M |
QUREUNIQURE NV | $19.0M |
AMRNAMARIN CORP PLC | $18.6M |
INCYINCYTE CORP | $18.3M |
MIRMMIRUM PHARMACEUTICALS INC | $17.4M |
APREAPREA THERAPEUTICS INC | $17.4M |
TBPHTHERAVANCE BIOPHARMA INC | $17.3M |
MDGLMADRIGAL PHARMACEUTICALS INC | $16.7M |
ACHCACADIA HEALTHCARE COMPANY IN | $16.5M |
NVTA1EURINVITAE CORP | $15.7M |
HQYHEALTHEQUITY INC | $15.4M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $15.1M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $14.3M |
—IMMUNOMEDICS INC | $14.2M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $13.8M |
JNJJOHNSON & JOHNSON | $13.8M |
GHGUARDANT HEALTH INC | $13.2M |
KRTXKARUNA THERAPEUTICS INC | $13.0M |
—RADIUS HEALTH INC | $12.7M |
—PORTOLA PHARMACEUTICALS INC | $12.5M |
INSPINSPIRE MED SYS INC | $12.1M |
PHRPHREESIA INC | $11.9M |
—ODONATE THERAPEUTICS INC | $11.9M |
NVCRNOVOCURE LTD | $11.8M |
ARVNARVINAS INC | $11.5M |
HCATHEALTH CATALYST INC | $11.1M |
—MOMENTA PHARMACEUTICALS INC | $10.9M |
WSTWEST PHARMACEUTICAL SVSC INC | $10.8M |
FGENEURFIBROGEN INC | $10.6M |
CYTK 4 11/15/26CYTOKINETICS INC | $10.6M |
ALLKGUSDALLAKOS INC | $10.5M |
CNMDCONMED CORP | $10.3M |
—ZOGENIX INC | $9.9M |
AM6AMICUS THERAPEUTICS INC | $9.2M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $8.6M |
—RETROPHIN INC | $8.4M |
—TRANSLATE BIO INC | $8.2M |
—PPD INC | $8.0M |
CGENCOMPUGEN LTD | $8.0M |
—MYOKARDIA INC | $7.7M |
RYTMRHYTHM PHARMACEUTICALS INC | $7.6M |
—CONSTELLATION PHARMCETICLS I | $7.3M |
—MERSANA THERAPEUTICS INC | $7.2M |
—IMARA INC | $7.1M |
—BIOHAVEN PHARMACTL HLDG CO L | $6.8M |
FIXXEURHOMOLOGY MEDICINES INC | $6.6M |
—INTERSECT ENT INC | $5.9M |
XENEXENON PHARMACEUTICALS INC | $5.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $5.6M |
PRTAPROTHENA CORP PLC | $5.3M |
INSM 1.75 01/15/25INSMED INC | $5.0M |
STAASTAAR SURGICAL CO | $5.0M |
TMOTHERMO FISHER SCIENTIFIC INC | $5.0M |
—CHIASMA INC | $4.9M |
SPROSPERO THERAPEUTICS INC | $4.9M |
ALLOALLOGENE THERAPEUTICS INC | $4.9M |
Page 1 of 2Next